nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—Epirubicin—bone cancer	0.302	0.375	CbGbCtD
Lomefloxacin—TOP2A—Doxorubicin—bone cancer	0.16	0.199	CbGbCtD
Lomefloxacin—ABCC2—Carboplatin—bone cancer	0.115	0.143	CbGbCtD
Lomefloxacin—ABCC2—Cisplatin—bone cancer	0.0982	0.122	CbGbCtD
Lomefloxacin—ABCC2—Doxorubicin—bone cancer	0.0658	0.0818	CbGbCtD
Lomefloxacin—ABCC2—Methotrexate—bone cancer	0.0637	0.0792	CbGbCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.00787	0.146	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00455	0.0844	CbGpPWpGaD
Lomefloxacin—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00347	0.0645	CbGpPWpGaD
Lomefloxacin—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00305	0.0567	CbGpPWpGaD
Lomefloxacin—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00286	0.0531	CbGpPWpGaD
Lomefloxacin—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.00195	0.0362	CbGpPWpGaD
Lomefloxacin—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00167	0.031	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00164	0.0305	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00128	0.0237	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00114	0.0212	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00108	0.02	CbGpPWpGaD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00101	0.0187	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000959	0.0178	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.000884	0.0164	CbGpPWpGaD
Lomefloxacin—TOP2A—Idarubicin—Epirubicin—bone cancer	0.000882	0.173	CbGdCrCtD
Lomefloxacin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000882	0.173	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000882	0.173	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000816	0.16	CbGdCrCtD
Lomefloxacin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000816	0.16	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.000816	0.16	CbGdCrCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000763	0.0142	CbGpPWpGaD
Lomefloxacin—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000658	0.0122	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000616	0.0114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000599	0.0111	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000574	0.0106	CbGpPWpGaD
Lomefloxacin—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000551	0.0102	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000537	0.00996	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.00053	0.00983	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000491	0.00911	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000489	0.00907	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000486	0.00902	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000463	0.0086	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000462	0.00857	CbGpPWpGaD
Lomefloxacin—Levofloxacin—CYP3A4—bone cancer	0.000434	0.36	CrCbGaD
Lomefloxacin—Ciprofloxacin—CYP3A4—bone cancer	0.000419	0.348	CrCbGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000415	0.00771	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—ZW10—bone cancer	0.000413	0.00767	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000401	0.00743	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000389	0.00722	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000378	0.00702	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000365	0.00677	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000363	0.00674	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00036	0.00668	CbGpPWpGaD
Lomefloxacin—Norfloxacin—CYP3A4—bone cancer	0.000352	0.292	CrCbGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.00035	0.0065	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000348	0.00646	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000344	0.00639	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00034	0.00631	CbGpPWpGaD
Lomefloxacin—Anaphylactic shock—Cisplatin—bone cancer	0.000319	0.00236	CcSEcCtD
Lomefloxacin—Oedema—Cisplatin—bone cancer	0.000319	0.00236	CcSEcCtD
Lomefloxacin—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000318	0.00235	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000317	0.00589	CbGpPWpGaD
Lomefloxacin—Cardiac failure—Doxorubicin—bone cancer	0.000316	0.00234	CcSEcCtD
Lomefloxacin—Hypoglycaemia—Doxorubicin—bone cancer	0.000316	0.00234	CcSEcCtD
Lomefloxacin—Ataxia—Epirubicin—bone cancer	0.000313	0.00232	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000313	0.00581	CbGpPWpGaD
Lomefloxacin—Thrombocytopenia—Cisplatin—bone cancer	0.000312	0.00231	CcSEcCtD
Lomefloxacin—Blood creatinine increased—Epirubicin—bone cancer	0.000312	0.00231	CcSEcCtD
Lomefloxacin—Tachycardia—Cisplatin—bone cancer	0.000311	0.0023	CcSEcCtD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00031	0.00576	CbGpPWpGaD
Lomefloxacin—Skin disorder—Cisplatin—bone cancer	0.00031	0.00229	CcSEcCtD
Lomefloxacin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000308	0.00228	CcSEcCtD
Lomefloxacin—Diplopia—Doxorubicin—bone cancer	0.000308	0.00228	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Cisplatin—bone cancer	0.000308	0.00228	CcSEcCtD
Lomefloxacin—Eosinophilia—Methotrexate—bone cancer	0.000305	0.00225	CcSEcCtD
Lomefloxacin—Anorexia—Cisplatin—bone cancer	0.000304	0.00225	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.0003	0.00222	CcSEcCtD
Lomefloxacin—Hypotension—Cisplatin—bone cancer	0.000298	0.0022	CcSEcCtD
Lomefloxacin—Face oedema—Doxorubicin—bone cancer	0.000297	0.0022	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000297	0.00551	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00029	0.00215	CcSEcCtD
Lomefloxacin—Ataxia—Doxorubicin—bone cancer	0.00029	0.00214	CcSEcCtD
Lomefloxacin—Blood creatinine increased—Doxorubicin—bone cancer	0.000289	0.00213	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000288	0.00534	CbGpPWpGaD
Lomefloxacin—Dysphagia—Epirubicin—bone cancer	0.000288	0.00213	CcSEcCtD
Lomefloxacin—Dysuria—Methotrexate—bone cancer	0.000288	0.00213	CcSEcCtD
Lomefloxacin—Paraesthesia—Cisplatin—bone cancer	0.000286	0.00212	CcSEcCtD
Lomefloxacin—Eosinophilia—Epirubicin—bone cancer	0.000285	0.00211	CcSEcCtD
Lomefloxacin—Dyspnoea—Cisplatin—bone cancer	0.000284	0.0021	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—RFC1—bone cancer	0.000284	0.00527	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000283	0.00525	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000282	0.00523	CbGpPWpGaD
Lomefloxacin—Photosensitivity reaction—Methotrexate—bone cancer	0.000281	0.00208	CcSEcCtD
Lomefloxacin—Angina pectoris—Epirubicin—bone cancer	0.00028	0.00207	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000277	0.00205	CcSEcCtD
Lomefloxacin—Decreased appetite—Cisplatin—bone cancer	0.000277	0.00205	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000275	0.00511	CbGpPWpGaD
Lomefloxacin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000272	0.00201	CcSEcCtD
Lomefloxacin—Renal failure—Methotrexate—bone cancer	0.00027	0.00199	CcSEcCtD
Lomefloxacin—Dysuria—Epirubicin—bone cancer	0.000269	0.00199	CcSEcCtD
Lomefloxacin—Stomatitis—Methotrexate—bone cancer	0.000267	0.00198	CcSEcCtD
Lomefloxacin—Conjunctivitis—Methotrexate—bone cancer	0.000267	0.00197	CcSEcCtD
Lomefloxacin—Dysphagia—Doxorubicin—bone cancer	0.000266	0.00197	CcSEcCtD
Lomefloxacin—Eosinophilia—Doxorubicin—bone cancer	0.000264	0.00195	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Epirubicin—bone cancer	0.000263	0.00194	CcSEcCtD
Lomefloxacin—Feeling abnormal—Cisplatin—bone cancer	0.000263	0.00194	CcSEcCtD
Lomefloxacin—Haematuria—Methotrexate—bone cancer	0.000261	0.00193	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Epirubicin—bone cancer	0.00026	0.00192	CcSEcCtD
Lomefloxacin—Angina pectoris—Doxorubicin—bone cancer	0.000259	0.00192	CcSEcCtD
Lomefloxacin—Epistaxis—Methotrexate—bone cancer	0.000259	0.00191	CcSEcCtD
Lomefloxacin—Agranulocytosis—Methotrexate—bone cancer	0.000256	0.00189	CcSEcCtD
Lomefloxacin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000256	0.00475	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000256	0.00475	CbGpPWpGaD
Lomefloxacin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000254	0.00188	CcSEcCtD
Lomefloxacin—Renal failure—Epirubicin—bone cancer	0.000252	0.00187	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Epirubicin—bone cancer	0.000252	0.00186	CcSEcCtD
Lomefloxacin—Stomatitis—Epirubicin—bone cancer	0.00025	0.00185	CcSEcCtD
Lomefloxacin—Conjunctivitis—Epirubicin—bone cancer	0.000249	0.00184	CcSEcCtD
Lomefloxacin—Dysuria—Doxorubicin—bone cancer	0.000249	0.00184	CcSEcCtD
Lomefloxacin—Hepatitis—Methotrexate—bone cancer	0.000246	0.00182	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.000245	0.00455	CbGpPWpGaD
Lomefloxacin—Haematuria—Epirubicin—bone cancer	0.000245	0.00181	CcSEcCtD
Lomefloxacin—Pharyngitis—Methotrexate—bone cancer	0.000244	0.00181	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Doxorubicin—bone cancer	0.000243	0.0018	CcSEcCtD
Lomefloxacin—Epistaxis—Epirubicin—bone cancer	0.000242	0.00179	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Doxorubicin—bone cancer	0.00024	0.00178	CcSEcCtD
Lomefloxacin—Agranulocytosis—Epirubicin—bone cancer	0.000239	0.00177	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000237	0.00441	CbGpPWpGaD
Lomefloxacin—Visual impairment—Methotrexate—bone cancer	0.000237	0.00175	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000235	0.00174	CcSEcCtD
Lomefloxacin—Hypersensitivity—Cisplatin—bone cancer	0.000235	0.00174	CcSEcCtD
Lomefloxacin—Bradycardia—Epirubicin—bone cancer	0.000235	0.00173	CcSEcCtD
Lomefloxacin—Renal failure—Doxorubicin—bone cancer	0.000233	0.00173	CcSEcCtD
Lomefloxacin—Erythema multiforme—Methotrexate—bone cancer	0.000233	0.00172	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Doxorubicin—bone cancer	0.000233	0.00172	CcSEcCtD
Lomefloxacin—Stomatitis—Doxorubicin—bone cancer	0.000231	0.00171	CcSEcCtD
Lomefloxacin—Rhinitis—Epirubicin—bone cancer	0.000231	0.00171	CcSEcCtD
Lomefloxacin—Conjunctivitis—Doxorubicin—bone cancer	0.000231	0.00171	CcSEcCtD
Lomefloxacin—Hepatitis—Epirubicin—bone cancer	0.00023	0.0017	CcSEcCtD
Lomefloxacin—Tinnitus—Methotrexate—bone cancer	0.00023	0.0017	CcSEcCtD
Lomefloxacin—Asthenia—Cisplatin—bone cancer	0.000229	0.00169	CcSEcCtD
Lomefloxacin—Pharyngitis—Epirubicin—bone cancer	0.000229	0.00169	CcSEcCtD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000229	0.00424	CbGpPWpGaD
Lomefloxacin—Haematuria—Doxorubicin—bone cancer	0.000226	0.00167	CcSEcCtD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000226	0.00419	CbGpPWpGaD
Lomefloxacin—Epistaxis—Doxorubicin—bone cancer	0.000224	0.00166	CcSEcCtD
Lomefloxacin—Visual impairment—Epirubicin—bone cancer	0.000222	0.00164	CcSEcCtD
Lomefloxacin—Agranulocytosis—Doxorubicin—bone cancer	0.000222	0.00164	CcSEcCtD
Lomefloxacin—Chills—Methotrexate—bone cancer	0.000221	0.00163	CcSEcCtD
Lomefloxacin—Diarrhoea—Cisplatin—bone cancer	0.000218	0.00161	CcSEcCtD
Lomefloxacin—Erythema multiforme—Epirubicin—bone cancer	0.000218	0.00161	CcSEcCtD
Lomefloxacin—Bradycardia—Doxorubicin—bone cancer	0.000217	0.0016	CcSEcCtD
Lomefloxacin—Tinnitus—Epirubicin—bone cancer	0.000215	0.00159	CcSEcCtD
Lomefloxacin—Flushing—Epirubicin—bone cancer	0.000214	0.00158	CcSEcCtD
Lomefloxacin—Rhinitis—Doxorubicin—bone cancer	0.000214	0.00158	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000214	0.00396	CbGpPWpGaD
Lomefloxacin—Hepatitis—Doxorubicin—bone cancer	0.000213	0.00158	CcSEcCtD
Lomefloxacin—Pharyngitis—Doxorubicin—bone cancer	0.000212	0.00156	CcSEcCtD
Lomefloxacin—Dysgeusia—Methotrexate—bone cancer	0.00021	0.00155	CcSEcCtD
Lomefloxacin—Back pain—Methotrexate—bone cancer	0.000207	0.00153	CcSEcCtD
Lomefloxacin—Chills—Epirubicin—bone cancer	0.000207	0.00153	CcSEcCtD
Lomefloxacin—Arrhythmia—Epirubicin—bone cancer	0.000206	0.00152	CcSEcCtD
Lomefloxacin—Visual impairment—Doxorubicin—bone cancer	0.000205	0.00152	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.000205	0.0038	CbGpPWpGaD
Lomefloxacin—Vomiting—Cisplatin—bone cancer	0.000203	0.0015	CcSEcCtD
Lomefloxacin—Erythema multiforme—Doxorubicin—bone cancer	0.000202	0.00149	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000201	0.00373	CbGpPWpGaD
Lomefloxacin—Rash—Cisplatin—bone cancer	0.000201	0.00149	CcSEcCtD
Lomefloxacin—Dermatitis—Cisplatin—bone cancer	0.000201	0.00148	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Methotrexate—bone cancer	0.000199	0.00147	CcSEcCtD
Lomefloxacin—Tinnitus—Doxorubicin—bone cancer	0.000199	0.00147	CcSEcCtD
Lomefloxacin—Anaemia—Methotrexate—bone cancer	0.000198	0.00146	CcSEcCtD
Lomefloxacin—Flushing—Doxorubicin—bone cancer	0.000198	0.00146	CcSEcCtD
Lomefloxacin—Flatulence—Epirubicin—bone cancer	0.000198	0.00146	CcSEcCtD
Lomefloxacin—Tension—Epirubicin—bone cancer	0.000197	0.00146	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000197	0.00365	CbGpPWpGaD
Lomefloxacin—Dysgeusia—Epirubicin—bone cancer	0.000196	0.00145	CcSEcCtD
Lomefloxacin—Nervousness—Epirubicin—bone cancer	0.000195	0.00144	CcSEcCtD
Lomefloxacin—Back pain—Epirubicin—bone cancer	0.000194	0.00143	CcSEcCtD
Lomefloxacin—Malaise—Methotrexate—bone cancer	0.000193	0.00143	CcSEcCtD
Lomefloxacin—Muscle spasms—Epirubicin—bone cancer	0.000193	0.00143	CcSEcCtD
Lomefloxacin—Vertigo—Methotrexate—bone cancer	0.000193	0.00142	CcSEcCtD
Lomefloxacin—Leukopenia—Methotrexate—bone cancer	0.000192	0.00142	CcSEcCtD
Lomefloxacin—Chills—Doxorubicin—bone cancer	0.000191	0.00141	CcSEcCtD
Lomefloxacin—Arrhythmia—Doxorubicin—bone cancer	0.00019	0.00141	CcSEcCtD
Lomefloxacin—Nausea—Cisplatin—bone cancer	0.000189	0.0014	CcSEcCtD
Lomefloxacin—Cough—Methotrexate—bone cancer	0.000187	0.00138	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Epirubicin—bone cancer	0.000186	0.00138	CcSEcCtD
Lomefloxacin—Convulsion—Methotrexate—bone cancer	0.000186	0.00137	CcSEcCtD
Lomefloxacin—Anaemia—Epirubicin—bone cancer	0.000185	0.00137	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000185	0.00344	CbGpPWpGaD
Lomefloxacin—Agitation—Epirubicin—bone cancer	0.000184	0.00136	CcSEcCtD
Lomefloxacin—Flatulence—Doxorubicin—bone cancer	0.000183	0.00135	CcSEcCtD
Lomefloxacin—Arthralgia—Methotrexate—bone cancer	0.000182	0.00135	CcSEcCtD
Lomefloxacin—Myalgia—Methotrexate—bone cancer	0.000182	0.00135	CcSEcCtD
Lomefloxacin—Chest pain—Methotrexate—bone cancer	0.000182	0.00135	CcSEcCtD
Lomefloxacin—Tension—Doxorubicin—bone cancer	0.000182	0.00135	CcSEcCtD
Lomefloxacin—Dysgeusia—Doxorubicin—bone cancer	0.000182	0.00134	CcSEcCtD
Lomefloxacin—Malaise—Epirubicin—bone cancer	0.000181	0.00134	CcSEcCtD
Lomefloxacin—Discomfort—Methotrexate—bone cancer	0.00018	0.00133	CcSEcCtD
Lomefloxacin—Nervousness—Doxorubicin—bone cancer	0.00018	0.00133	CcSEcCtD
Lomefloxacin—Vertigo—Epirubicin—bone cancer	0.00018	0.00133	CcSEcCtD
Lomefloxacin—Syncope—Epirubicin—bone cancer	0.00018	0.00133	CcSEcCtD
Lomefloxacin—Leukopenia—Epirubicin—bone cancer	0.00018	0.00133	CcSEcCtD
Lomefloxacin—Back pain—Doxorubicin—bone cancer	0.000179	0.00133	CcSEcCtD
Lomefloxacin—Muscle spasms—Doxorubicin—bone cancer	0.000178	0.00132	CcSEcCtD
Lomefloxacin—Confusional state—Methotrexate—bone cancer	0.000176	0.0013	CcSEcCtD
Lomefloxacin—Loss of consciousness—Epirubicin—bone cancer	0.000176	0.0013	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—DHFR—bone cancer	0.000176	0.00327	CbGpPWpGaD
Lomefloxacin—Cough—Epirubicin—bone cancer	0.000175	0.00129	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Methotrexate—bone cancer	0.000175	0.00129	CcSEcCtD
Lomefloxacin—Convulsion—Epirubicin—bone cancer	0.000174	0.00129	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000174	0.00322	CbGpPWpGaD
Lomefloxacin—Hypertension—Epirubicin—bone cancer	0.000173	0.00128	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Doxorubicin—bone cancer	0.000172	0.00127	CcSEcCtD
Lomefloxacin—Anaemia—Doxorubicin—bone cancer	0.000172	0.00127	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Methotrexate—bone cancer	0.000171	0.00127	CcSEcCtD
Lomefloxacin—Chest pain—Epirubicin—bone cancer	0.000171	0.00126	CcSEcCtD
Lomefloxacin—Arthralgia—Epirubicin—bone cancer	0.000171	0.00126	CcSEcCtD
Lomefloxacin—Myalgia—Epirubicin—bone cancer	0.000171	0.00126	CcSEcCtD
Lomefloxacin—Agitation—Doxorubicin—bone cancer	0.000171	0.00126	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.00017	0.00316	CbGpPWpGaD
Lomefloxacin—Anxiety—Epirubicin—bone cancer	0.00017	0.00126	CcSEcCtD
Lomefloxacin—Skin disorder—Methotrexate—bone cancer	0.00017	0.00126	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Methotrexate—bone cancer	0.000169	0.00125	CcSEcCtD
Lomefloxacin—Discomfort—Epirubicin—bone cancer	0.000169	0.00125	CcSEcCtD
Lomefloxacin—Malaise—Doxorubicin—bone cancer	0.000167	0.00124	CcSEcCtD
Lomefloxacin—Dry mouth—Epirubicin—bone cancer	0.000167	0.00123	CcSEcCtD
Lomefloxacin—Vertigo—Doxorubicin—bone cancer	0.000167	0.00123	CcSEcCtD
Lomefloxacin—Anorexia—Methotrexate—bone cancer	0.000167	0.00123	CcSEcCtD
Lomefloxacin—Syncope—Doxorubicin—bone cancer	0.000166	0.00123	CcSEcCtD
Lomefloxacin—Leukopenia—Doxorubicin—bone cancer	0.000166	0.00123	CcSEcCtD
Lomefloxacin—Confusional state—Epirubicin—bone cancer	0.000165	0.00122	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Epirubicin—bone cancer	0.000164	0.00121	CcSEcCtD
Lomefloxacin—Oedema—Epirubicin—bone cancer	0.000164	0.00121	CcSEcCtD
Lomefloxacin—Hypotension—Methotrexate—bone cancer	0.000163	0.00121	CcSEcCtD
Lomefloxacin—Loss of consciousness—Doxorubicin—bone cancer	0.000163	0.00121	CcSEcCtD
Lomefloxacin—Cough—Doxorubicin—bone cancer	0.000162	0.0012	CcSEcCtD
Lomefloxacin—Shock—Epirubicin—bone cancer	0.000161	0.00119	CcSEcCtD
Lomefloxacin—Convulsion—Doxorubicin—bone cancer	0.000161	0.00119	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Epirubicin—bone cancer	0.00016	0.00119	CcSEcCtD
Lomefloxacin—Hypertension—Doxorubicin—bone cancer	0.00016	0.00118	CcSEcCtD
Lomefloxacin—Tachycardia—Epirubicin—bone cancer	0.00016	0.00118	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000159	0.00118	CcSEcCtD
Lomefloxacin—Skin disorder—Epirubicin—bone cancer	0.000159	0.00118	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000158	0.00294	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Epirubicin—bone cancer	0.000158	0.00117	CcSEcCtD
Lomefloxacin—Insomnia—Methotrexate—bone cancer	0.000158	0.00117	CcSEcCtD
Lomefloxacin—Chest pain—Doxorubicin—bone cancer	0.000158	0.00117	CcSEcCtD
Lomefloxacin—Myalgia—Doxorubicin—bone cancer	0.000158	0.00117	CcSEcCtD
Lomefloxacin—Arthralgia—Doxorubicin—bone cancer	0.000158	0.00117	CcSEcCtD
Lomefloxacin—Anxiety—Doxorubicin—bone cancer	0.000157	0.00116	CcSEcCtD
Lomefloxacin—Paraesthesia—Methotrexate—bone cancer	0.000157	0.00116	CcSEcCtD
Lomefloxacin—Discomfort—Doxorubicin—bone cancer	0.000156	0.00115	CcSEcCtD
Lomefloxacin—Anorexia—Epirubicin—bone cancer	0.000156	0.00115	CcSEcCtD
Lomefloxacin—Dyspnoea—Methotrexate—bone cancer	0.000156	0.00115	CcSEcCtD
Lomefloxacin—Somnolence—Methotrexate—bone cancer	0.000155	0.00115	CcSEcCtD
Lomefloxacin—Dry mouth—Doxorubicin—bone cancer	0.000155	0.00114	CcSEcCtD
Lomefloxacin—Dyspepsia—Methotrexate—bone cancer	0.000154	0.00114	CcSEcCtD
Lomefloxacin—Hypotension—Epirubicin—bone cancer	0.000153	0.00113	CcSEcCtD
Lomefloxacin—Confusional state—Doxorubicin—bone cancer	0.000153	0.00113	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000153	0.00283	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000152	0.00283	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Methotrexate—bone cancer	0.000152	0.00112	CcSEcCtD
Lomefloxacin—Oedema—Doxorubicin—bone cancer	0.000151	0.00112	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Doxorubicin—bone cancer	0.000151	0.00112	CcSEcCtD
Lomefloxacin—Fatigue—Methotrexate—bone cancer	0.000151	0.00112	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000149	0.0011	CcSEcCtD
Lomefloxacin—Shock—Doxorubicin—bone cancer	0.000149	0.0011	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Doxorubicin—bone cancer	0.000148	0.0011	CcSEcCtD
Lomefloxacin—Insomnia—Epirubicin—bone cancer	0.000148	0.00109	CcSEcCtD
Lomefloxacin—Tachycardia—Doxorubicin—bone cancer	0.000148	0.00109	CcSEcCtD
Lomefloxacin—Skin disorder—Doxorubicin—bone cancer	0.000147	0.00109	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CHEK2—bone cancer	0.000147	0.00273	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Epirubicin—bone cancer	0.000147	0.00109	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Doxorubicin—bone cancer	0.000146	0.00108	CcSEcCtD
Lomefloxacin—Dyspnoea—Epirubicin—bone cancer	0.000146	0.00108	CcSEcCtD
Lomefloxacin—Somnolence—Epirubicin—bone cancer	0.000146	0.00108	CcSEcCtD
Lomefloxacin—Anorexia—Doxorubicin—bone cancer	0.000144	0.00107	CcSEcCtD
Lomefloxacin—Feeling abnormal—Methotrexate—bone cancer	0.000144	0.00107	CcSEcCtD
Lomefloxacin—Dyspepsia—Epirubicin—bone cancer	0.000144	0.00107	CcSEcCtD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000144	0.00267	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Methotrexate—bone cancer	0.000143	0.00106	CcSEcCtD
Lomefloxacin—Decreased appetite—Epirubicin—bone cancer	0.000142	0.00105	CcSEcCtD
Lomefloxacin—Hypotension—Doxorubicin—bone cancer	0.000142	0.00105	CcSEcCtD
Lomefloxacin—Fatigue—Epirubicin—bone cancer	0.000141	0.00104	CcSEcCtD
Lomefloxacin—Constipation—Epirubicin—bone cancer	0.00014	0.00104	CcSEcCtD
Lomefloxacin—Urticaria—Methotrexate—bone cancer	0.000139	0.00103	CcSEcCtD
Lomefloxacin—Abdominal pain—Methotrexate—bone cancer	0.000138	0.00102	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000138	0.00102	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000138	0.00255	CbGpPWpGaD
Lomefloxacin—Insomnia—Doxorubicin—bone cancer	0.000137	0.00101	CcSEcCtD
Lomefloxacin—Paraesthesia—Doxorubicin—bone cancer	0.000136	0.00101	CcSEcCtD
Lomefloxacin—Dyspnoea—Doxorubicin—bone cancer	0.000135	0.000999	CcSEcCtD
Lomefloxacin—Feeling abnormal—Epirubicin—bone cancer	0.000135	0.000998	CcSEcCtD
Lomefloxacin—Somnolence—Doxorubicin—bone cancer	0.000135	0.000996	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Epirubicin—bone cancer	0.000134	0.00099	CcSEcCtD
Lomefloxacin—Dyspepsia—Doxorubicin—bone cancer	0.000133	0.000986	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUN—bone cancer	0.000132	0.00245	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Doxorubicin—bone cancer	0.000132	0.000974	CcSEcCtD
Lomefloxacin—Fatigue—Doxorubicin—bone cancer	0.000131	0.000966	CcSEcCtD
Lomefloxacin—Urticaria—Epirubicin—bone cancer	0.00013	0.000962	CcSEcCtD
Lomefloxacin—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.00013	0.00241	CbGpPWpGaD
Lomefloxacin—Constipation—Doxorubicin—bone cancer	0.00013	0.000958	CcSEcCtD
Lomefloxacin—Abdominal pain—Epirubicin—bone cancer	0.000129	0.000957	CcSEcCtD
Lomefloxacin—Hypersensitivity—Methotrexate—bone cancer	0.000129	0.000953	CcSEcCtD
Lomefloxacin—Asthenia—Methotrexate—bone cancer	0.000125	0.000928	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000125	0.00233	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Doxorubicin—bone cancer	0.000125	0.000923	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—BRCA2—bone cancer	0.000125	0.00231	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000124	0.000916	CcSEcCtD
Lomefloxacin—Pruritus—Methotrexate—bone cancer	0.000124	0.000915	CcSEcCtD
Lomefloxacin—Hypersensitivity—Epirubicin—bone cancer	0.000121	0.000892	CcSEcCtD
Lomefloxacin—Urticaria—Doxorubicin—bone cancer	0.00012	0.00089	CcSEcCtD
Lomefloxacin—Abdominal pain—Doxorubicin—bone cancer	0.00012	0.000885	CcSEcCtD
Lomefloxacin—Diarrhoea—Methotrexate—bone cancer	0.00012	0.000885	CcSEcCtD
Lomefloxacin—Asthenia—Epirubicin—bone cancer	0.000117	0.000869	CcSEcCtD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.000117	0.00218	CbGpPWpGaD
Lomefloxacin—Pruritus—Epirubicin—bone cancer	0.000116	0.000856	CcSEcCtD
Lomefloxacin—Dizziness—Methotrexate—bone cancer	0.000116	0.000855	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000113	0.0021	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Epirubicin—bone cancer	0.000112	0.000828	CcSEcCtD
Lomefloxacin—Hypersensitivity—Doxorubicin—bone cancer	0.000112	0.000825	CcSEcCtD
Lomefloxacin—Vomiting—Methotrexate—bone cancer	0.000111	0.000822	CcSEcCtD
Lomefloxacin—Rash—Methotrexate—bone cancer	0.00011	0.000816	CcSEcCtD
Lomefloxacin—Dermatitis—Methotrexate—bone cancer	0.00011	0.000815	CcSEcCtD
Lomefloxacin—Headache—Methotrexate—bone cancer	0.00011	0.00081	CcSEcCtD
Lomefloxacin—Asthenia—Doxorubicin—bone cancer	0.000109	0.000804	CcSEcCtD
Lomefloxacin—Dizziness—Epirubicin—bone cancer	0.000108	0.000801	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000108	0.00201	CbGpPWpGaD
Lomefloxacin—Pruritus—Doxorubicin—bone cancer	0.000107	0.000792	CcSEcCtD
Lomefloxacin—Vomiting—Epirubicin—bone cancer	0.000104	0.00077	CcSEcCtD
Lomefloxacin—Nausea—Methotrexate—bone cancer	0.000104	0.000768	CcSEcCtD
Lomefloxacin—Diarrhoea—Doxorubicin—bone cancer	0.000104	0.000766	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	0.000103	0.00192	CbGpPWpGaD
Lomefloxacin—Rash—Epirubicin—bone cancer	0.000103	0.000763	CcSEcCtD
Lomefloxacin—Dermatitis—Epirubicin—bone cancer	0.000103	0.000763	CcSEcCtD
Lomefloxacin—Headache—Epirubicin—bone cancer	0.000103	0.000758	CcSEcCtD
Lomefloxacin—Dizziness—Doxorubicin—bone cancer	0.0001	0.000741	CcSEcCtD
Lomefloxacin—CYP1A2—Biological oxidations—CYP3A4—bone cancer	9.85e-05	0.00183	CbGpPWpGaD
Lomefloxacin—Nausea—Epirubicin—bone cancer	9.72e-05	0.000719	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	9.71e-05	0.0018	CbGpPWpGaD
Lomefloxacin—Vomiting—Doxorubicin—bone cancer	9.63e-05	0.000712	CcSEcCtD
Lomefloxacin—Rash—Doxorubicin—bone cancer	9.55e-05	0.000706	CcSEcCtD
Lomefloxacin—Dermatitis—Doxorubicin—bone cancer	9.54e-05	0.000706	CcSEcCtD
Lomefloxacin—Headache—Doxorubicin—bone cancer	9.49e-05	0.000702	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDK4—bone cancer	9.24e-05	0.00172	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	9.08e-05	0.00169	CbGpPWpGaD
Lomefloxacin—Nausea—Doxorubicin—bone cancer	9e-05	0.000665	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	8.99e-05	0.00167	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	8.88e-05	0.00165	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	8.88e-05	0.00165	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—bone cancer	8.72e-05	0.00162	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—bone cancer	8.42e-05	0.00156	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	8.3e-05	0.00154	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—RB1—bone cancer	8.04e-05	0.00149	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MDM2—bone cancer	6.85e-05	0.00127	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NDUFA12—bone cancer	5.9e-05	0.0011	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NT5C3A—bone cancer	4.89e-05	0.000908	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—bone cancer	3.93e-05	0.00073	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENO2—bone cancer	2.14e-05	0.000398	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—DHFR—bone cancer	1.99e-05	0.000369	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GNA11—bone cancer	1.86e-05	0.000345	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000313	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.68e-05	0.000311	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—bone cancer	1.44e-05	0.000267	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—bone cancer	7.46e-06	0.000138	CbGpPWpGaD
